POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
Richard Wilson
Gilead already has Complera and Stribild yet they keep pushing Atripla. There are perfectly good alternatives (unless you simply have to use Sustiva). Gilead would do well to promote these other combos and phase Atripla out of their portfolio. Urgh.
December 2, 2014 • Chciago